Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China · Delayed Price · Currency is CNY 12.48
+0.12 (0.97%)
Jul 29, 2026, 3:07 PM CST
SHE:300401 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,188 | 1,237 | 1,243 | 1,095 | 1,418 | 1,117 |
Revenue Growth | -4.16% | -0.47% | 13.58% | -22.78% | 26.89% | 69.40% |
Gross Profit Gross Profit Growth | 631.43 | 681.52 | 723.7 | 653.25 | 931.14 | 766.44 |
Operating Income Operating Income Growth | 318.33 | 360.63 | 315.86 | 169.51 | 397.48 | 445.75 |
Net Income Net Income Growth | 258.62 | 304.86 | 309.21 | 192.35 | 383.72 | 483.77 |
Earnings Per Share EPS Growth | 0.43 | 0.51 | 0.52 | 0.32 | 0.70 | 0.89 |
EPS Growth | -21.40% | -1.92% | 62.50% | -54.29% | -21.35% | 71.15% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Pharmaceutical Division Pharmaceutical Division Growth | 356.29 | 434.18 |
Vitamin Division Vitamin Division Growth | 882.19 | 809.1 |
Offset of Business Segment Offset of Business Segment Growth | -1.08 | - |
Total Total Growth | 1,237 | 1,243 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,639 | 1,334 | 1,425 | 1,503 | 554.91 | 502.49 |
Total Debt Total Debt Growth | 1,734 | 1,749 | 1,715 | 1,586 | 532.39 | 414.57 |
Net Cash (Debt) Net Cash Growth | -94.95 | -415.78 | -290.5 | -83.59 | 22.52 | 87.93 |
Net Cash Growth | - | - | - | - | -74.39% | -92.15% |
Net Cash Per Share Net Cash Per Share Growth | -0.16 | -0.70 | -0.49 | -0.14 | 0.04 | 0.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 530.3 | 474.74 | 466.41 | 159.98 | 377.04 | 512.25 |
Capital Expenditures CapEx Growth | -333.23 | -361.96 | -480.38 | -244.55 | -379.93 | -715.58 |
Free Cash Flow Free Cash Flow Growth | 197.07 | 112.78 | -13.97 | -84.57 | -2.89 | -203.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 53.16% | 55.08% | 58.21% | 59.68% | 65.69% | 68.61% |
Operating Margin | 26.80% | 29.14% | 25.41% | 15.48% | 28.04% | 39.90% |
Pretax Margin | 25.06% | 28.49% | 28.85% | 19.28% | 31.22% | 52.76% |
Profit Margin | 21.77% | 24.64% | 24.87% | 17.57% | 27.07% | 43.31% |
FCF Margin | 16.59% | 9.11% | -1.12% | -7.72% | -0.20% | -18.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.113 | 0.113 | 0.114 | 0.071 | 0.140 | 0.188 |
Dividend Per Share Growth | -0.88% | -0.88% | 60.56% | -49.29% | -25.53% | 82.52% |
Dividend Yield | 0.91% | 0.75% | 0.79% | 0.61% | 1.01% | 1.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 28.84 | 26.95 | 25.77 | 33.72 | 20.66 | 16.15 |
Forward PE | 15.45 | 16.00 | 18.18 | 9.98 | 12.09 | 15.59 |
P/FCF Ratio | 34.10 | 72.86 | - | - | - | - |
PS Ratio | 5.66 | 6.64 | 6.41 | 5.93 | 5.59 | 6.99 |